您当前的位置:
首页 >
文章列表页 >
Role of imaging in evaluating neoajubant chemotherapy for breast cancer
更新时间:2025-12-15
    • Role of imaging in evaluating neoajubant chemotherapy for breast cancer

    • Vol. 29, Issue 2, Pages: 65-71(2020)
    • DOI:10.19732/j.cnki.2096-6210.2020.02.001    

      CLC:
    • Published Online:28 April 2020

      Published:28 April 2020

    移动端阅览

  • org/10.19732/j.cnki.2096-6210.2020.02.001 DOI:

  •  
  •  
icon
试读结束,您可以激活您的VIP账号继续阅读。
去激活 >
icon
试读结束,您可以通过登录账户,到个人中心,购买VIP会员阅读全文。
已是VIP会员?
去登录 >

0

Views

1801

下载量

16

CNKI被引量

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Prediction of treating response for breast cancer by multi-phase MRI histogram arrays
Multimodal ultrasound features combined with serum CEA and CK19 to predict axillary lymph node metastasis of breast cancer
The predictive value of nomogram scoring model based on ultrasound and clinicopathological features to predict pCR in HER2 positive breast cancer after NAC
The application value of dynamic contrast-enhanced magnetic resonance imaging quantitative parameters in the evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer and its correlation with biological prognostic factors
Clinical value of calcification afterneoadjuvant chemotherapy in breast cancer

Related Author

ZHU Haitao
LI Xiaoting
QU Yuhong
SUN Yingshi
Yuqing HE
Zizheng WU
Shuai GUO
Zhengqin QI

Related Institution

Department of Radiology, Peking University Cancer Hospital
Department of Radiology, Affiliated Beijing Chaoyang Hospital of Capital Medical University
Department of Ultrasound, The First Hospital of Qinhuangdao
Qinhuangdao Health School, Qin Huangdao
Department of Ultrasound, The First Affiliated Hospital of Nanjing Medical University
0